Enliven Therapeutics - 6 Year Stock Price History | ELVN

Historical daily share price chart and data for Enliven Therapeutics since 2020 adjusted for splits and dividends. The latest closing stock price for Enliven Therapeutics as of June 22, 2026 is 45.96.
  • The all-time high Enliven Therapeutics stock closing price was 219.48 on June 11, 2020.
  • The Enliven Therapeutics 52-week high stock price is 48.53, which is 5.6% above the current share price.
  • The Enliven Therapeutics 52-week low stock price is 14.79, which is 67.8% below the current share price.
  • The average Enliven Therapeutics stock price for the last 52 weeks is 26.80.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Enliven Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2026 34.4012 15.5400 48.1100 15.1400 45.9600 198.44%
2025 20.1201 23.9000 24.4250 14.9100 15.4000 -31.56%
2024 21.4417 14.9000 29.5500 11.2400 22.5000 62.57%
2023 17.3821 15.7600 25.2800 10.1300 13.8400 -15.40%
2022 8.3533 9.6400 20.8000 3.9600 16.3600 81.78%
2021 28.6599 95.9200 95.9200 9.0000 9.0000 -89.80%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.799B $0.000B
Enliven Therapeutics Inc. is a clinical-stage precision oncology company focused on the discovery and development of small molecule kinase inhibitors. The Company's lead product candidate includes ELVN-001 and ELVN-002. Enliven Therapeutics Inc., formerly known as Imara Inc., is based in Boulder, CO.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) JP $76.559B 25.84
UCB SA (UCBJY) BE $53.468B 0.00
Takeda Pharmaceutical (TAK) JP $49.234B 8.99
Sandoz Group AG (SDZNY) CH $37.752B 0.00
Otsuka Holdings, - (OTSKY) JP $35.394B 13.90
Zoetis (ZTS) US $31.815B 11.73
BeOne Medicines - (ONC) CH $29.822B 60.81
Daiichi Sankyo, - (DSNKY) JP $29.359B 16.77
Astellas Pharma (ALPMY) JP $24.376B 9.16
United Therapeutics (UTHR) US $22.849B 19.87
Merck (MKKGY) DE $19.748B 13.58
Neurocrine Biosciences (NBIX) US $16.251B 27.21
IPSEN (IPSEY) FR $15.217B 0.00
Shionogi (SGIOY) JP $14.807B 10.88
Ionis Pharmaceuticals (IONS) US $12.542B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) IT $11.965B 15.63
Madrigal Pharmaceuticals (MDGL) US $11.825B 0.00
Summit Therapeutics (SMMT) US $11.084B 0.00
Orion OYJ (ORINY) FI $10.968B 17.83
Corcept Therapeutics (CORT) US $8.557B 227.74
Eisai (ESAIY) $7.000B 0.00
Ono Pharmaceutical (OPHLF) JP $6.344B 13.64
Centessa Pharmaceuticals (CNTA) GB $6.217B 0.00
Oruka Therapeutics (ORKA) US $5.149B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) US $5.139B 19.65
Stevanato Group S.p.A (STVN) IT $5.130B 27.32
Grifols, S.A (GRFS) ES $4.955B 0.00
Indivior Pharmaceuticals (INDV) US $4.672B 12.73
Hikma Pharmaceuticals Plc (HKMPF) GB $4.280B 0.00
Catalyst Pharmaceuticals (CPRX) US $3.842B 11.89
Crinetics Pharmaceuticals (CRNX) US $3.730B 0.00
Definium Therapeutics (DFTX) US $3.656B 0.00
NewAmsterdam Pharma (NAMS) NL $3.603B 0.00
Dyne Therapeutics (DYN) US $3.450B 0.00
Relay Therapeutics (RLAY) US $3.311B 0.00
Hypermarcas (HYPMY) BR $2.753B 8.15
Soleno Therapeutics (SLNO) United States $2.717B 228.83
BioCryst Pharmaceuticals (BCRX) US $2.323B 7.03
Aurinia Pharmaceuticals Inc (AUPH) CA $2.254B 19.48
Nektar Therapeutics (NKTR) US $2.220B 0.00
Ocular Therapeutix (OCUL) US $2.183B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
Guardian Pharmacy Services (GRDN) US $2.085B 41.89
Amylyx Pharmaceuticals (AMLX) US $1.810B 0.00
Harrow (HROW) US $1.581B 212.05
Ardelyx (ARDX) US $1.574B 0.00
Aktis Oncology (AKTS) US $1.324B 0.00
Xeris Biopharma Holdings (XERS) US $1.191B 115.00
Savara (SVRA) US $1.166B 0.00
Collegium Pharmaceutical (COLL) US $1.085B 4.86
Xencor (XNCR) US $1.039B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
ARS Pharmaceuticals (SPRY) US $0.991B 0.00
Cronos Group (CRON) CA $0.989B 0.00
Evotec AG (EVO) DE $0.932B 0.00
Avalo Therapeutics (AVTX) US $0.898B 0.00
Theravance Biopharma (TBPH) US $0.854B 17.25
Esperion Therapeutics (ESPR) US $0.814B 0.00
Zevra Therapeutics (ZVRA) US $0.748B 9.96
Bioventus (BVS) US $0.734B 11.72
Relmada Therapeutics (RLMD) US $0.723B 0.00
Aclaris Therapeutics (ACRS) US $0.676B 0.00
Rigel Pharmaceuticals (RIGL) US $0.661B 5.65
Ironwood Pharmaceuticals (IRWD) US $0.623B 6.26
Aquestive Therapeutics (AQST) US $0.592B 0.00
Altimmune (ALT) US $0.570B 0.00
ProKidney (PROK) US $0.550B 0.00
4D Molecular Therapeutics (FDMT) US $0.545B 0.00
Achieve Life Sciences (ACHV) CA $0.524B 0.00
Indaptus Therapeutics (INDP) US $0.427B 0.00
Century Therapeutics (IPSC) US $0.415B 0.00
Lexeo Therapeutics (LXEO) US $0.396B 0.00
Elite Pharmaceuticals (ELTP) US $0.390B 36.25
Larimar Therapeutics (LRMR) US $0.380B 0.00
Nature's Sunshine Products (NATR) US $0.359B 15.57
Silence Therapeutics (SLN) GB $0.356B 0.00
USANA Health Sciences (USNA) US $0.349B 10.50
Prelude Therapeutics (PRLD) US $0.344B 0.00
OmniAb (OABI) US $0.336B 0.00
Organogenesis (ORGO) US $0.313B 81.00
Siga Technologies (SIGA) US $0.311B 16.04
Akebia Therapeutics (AKBA) US $0.292B 0.00
Lyell Immunopharma (LYEL) US $0.279B 0.00
Surrozen (SRZN) US $0.275B 0.00
Cybin (HELP) CA $0.250B 0.00
Inhibikase Therapeutics (IKT) US $0.243B 0.00
Profound Medical (PROF) CA $0.238B 0.00
Protara Therapeutics (TARA) US $0.231B 0.00
Minerva Neurosciences (NERV) US $0.217B 0.00
Unicycive Therapeutics (UNCY) US $0.216B 0.00
Karyopharm Therapeutics (KPTI) US $0.204B 0.00
Korro Bio (KRRO) US $0.200B 0.00
AleAnna (ANNA) US $0.195B 20.93
Tonix Pharmaceuticals Holding (TNXP) US $0.194B 0.00
Galectin Therapeutics (GALT) US $0.184B 0.00
MediWound (MDWD) IL $0.179B 0.00
Journey Medical (DERM) US $0.177B 0.00
Corbus Pharmaceuticals Holdings (CRBP) US $0.154B 0.00
Enlivex (ENLV) IL $0.148B 0.00
Rafael Holdings (RFL) US $0.143B 0.00
NRx Pharmaceuticals (NRXP) US $0.141B 0.00
Innate Pharma SA (IPHYF) FR $0.138B 0.00
Fractyl Health (GUTS) US $0.138B 0.00
Pyxis Oncology (PYXS) US $0.135B 0.00
Veraxa Biotech AG (VRXA) US $0.131B 0.00
VAXART, INC (VXRT) US $0.130B 3.57
Avita Medical (RCEL) US $0.124B 0.00
Aldeyra Therapeutics (ALDX) US $0.124B 0.00
Cardiol Therapeutics (CRDL) CA $0.122B 0.00
Assertio Holdings (ASRT) United States $0.116B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
PolyPid (PYPD) IL $0.098B 0.00
Vivani Medical (VANI) US $0.097B 0.00
Verrica Pharmaceuticals (VRCA) US $0.097B 0.00
China SXT Pharmaceuticals (SXTC) CN $0.091B 0.00
Allergy Therapeutics (AGYTF) GB $0.090B 0.00
Telomir Pharmaceuticals (TELO) US $0.088B 0.00
Champions Oncology (CSBR) US $0.087B 0.00
Cumberland Pharmaceuticals (CPIX) US $0.083B 0.00
Heron Therapeutics (HRTX) US $0.081B 0.00
Gain Therapeutics (GANX) US $0.079B 0.00
Dominari Holdings (DOMH) US $0.072B 0.00
Acrivon Therapeutics (ACRV) US $0.068B 0.00
ElectroCore (ECOR) US $0.067B 0.00
PMV Pharmaceuticals (PMVP) US $0.061B 0.00
Context Therapeutics (CNTX) US $0.058B 0.00
Procaps Group, S.A (PROCF) LU $0.058B 0.00
Alaunos Therapeutics (TCRT) US $0.053B 0.00
Talphera (TLPH) US $0.051B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Incannex Healthcare (IXHL) AU $0.039B 0.00
Nutriband (NTRB) US $0.038B 0.00
SCYNEXIS (SCYX) US $0.038B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Lite Strategy (LITS) US $0.030B 0.00
Plus Therapeutics (PSTV) US $0.027B 0.00
TherapeuticsMD (TXMD) US $0.023B 0.00
MARKER THERAPEUTICS, INC (MRKR) US $0.023B 0.00
VYNE Therapeutics (VYNE) US $0.022B 0.00
Lipocine (LPCN) US $0.019B 0.00
Tempest Therapeutics (TPST) US $0.019B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) US $0.016B 0.00
Natural Alternatives (NAII) US $0.016B 0.00
Scienture Holdings (SCNX) US $0.016B 0.00
Vyome Holdings (HIND) US $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
BioVie (BIVI) US $0.015B 0.00
BioLineRx (BLRX) IL $0.014B 0.00
Cosmos Health (COSM) US $0.013B 0.00
Phio Pharmaceuticals (PHIO) US $0.012B 0.00
Kiora Pharmaceuticals (KPRX) US $0.011B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
Mannatech (MTEX) US $0.010B 0.00
Traws Pharma (TRAW) US $0.009B 0.00
Quoin Pharmaceuticals (QNRX) US $0.009B 0.00
Jupiter Neurosciences (JUNS) US $0.008B 0.00
Nuvilex (PMCB) US $0.008B 0.00
Addex Therapeutics (ADXN) CH $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
Curanex Pharmaceuticals Inc (CURX) US $0.008B 0.00
Wellgistics Health (WGRX) US $0.008B 0.00
CDT Equity (CDT) US $0.007B 0.00
Ernexa Therapeutics (ERNA) US $0.007B 0.00
Xenetic Biosciences (XBIO) US $0.007B 0.00
XTL Biopharmaceuticals (XTLB) IL $0.006B 0.00
Heatwurx (PCSA) US $0.006B 0.00
Biomerica (BMRA) US $0.006B 0.00
Vivos Therapeutics (VVOS) US $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) US $0.006B 0.00
Aptorum Group (APM) GB $0.005B 0.00
Liminatus Pharma (LIMN) US $0.005B 0.00
Mangoceuticals (MGRX) US $0.005B 0.00
InMed Pharmaceuticals (INM) CA $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
TransCode Therapeutics (RNAZ) US $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) US $0.004B 0.00
Redhill Biopharma (RDHL) IL $0.004B 0.00
SciSparc (SPRC) IL $0.004B 0.00
XORTX Therapeutics (XRTX) CA $0.004B 0.00
Galmed Pharmaceuticals (GLMD) IL $0.003B 0.00
Clearmind Medicine (CMND) CA $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) US $0.002B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.002B 0.00
Jaguar Animal Health (JAGX) US $0.002B 0.00
PainReform (PRFX) IL $0.001B 0.00
Aditxt (ADTX) US $0.000B 0.00
Emisphere Technologies (EMIS) US $0.000B 0.00
4D Pharma (LBPS) GB $0.000B 0.00
Patheon (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals (RVLP) US $0.000B 0.00